Rob Walton joined Fipra as a Special Adviser for healthcare in March 2010.

Rob has a wealth of experience in healthcare and pharmaceutical policy, having held a number of senior international roles in pharmaceutical companies in both the United States and Europe. Rob has particular expertise in public health management, access to healthcare in aspiring nations and the financing of healthcare in developed countries. In addition Rob has a developed an in-depth knowledge of healthcare policy pertaining to HIV/AIDS, Hepatitis, Cardiovascular Disease, Dementia Care, Mental Health and Pain Management.Rob graduated in Law from the University of Staffordshire and more recently obtained a Masters in Public Administration from the University of Columbia’s School of International Public Affairs in the City of New York.